Literature DB >> 21847642

The vitamin D pathway and mammographic breast density among postmenopausal women.

Brian L Sprague1, Amy Trentham-Dietz, Ronald E Gangnon, Diana S M Buist, Elizabeth S Burnside, Erin J Aiello Bowles, Frank Z Stanczyk, Gale S Sisney, Halcyon G Skinner.   

Abstract

Laboratory studies have demonstrated that vitamin D has a number of chemopreventive properties, and that these properties may be mediated or modified by other molecules in the vitamin D pathway, such as parathyroid hormone (PTH) or calcium. However, there is little epidemiologic data exploring the effects of vitamin D on breast cancer risk in the context of these other molecules. We examined a panel of molecules in the vitamin D pathway in relation to mammographic breast density, a marker of breast cancer risk, in the Wisconsin Breast Density Study. A total of 238 postmenopausal women (ages 55-70, with no history of postmenopausal hormone use) were enrolled from mammography clinics in Madison, Wisconsin. Subjects provided blood samples that were analyzed for levels of 25-hydroxy vitamin D [25(OH)D], PTH, insulin-like growth factor-1 (IGF-1), IGF-binding protein 3 (IGFBP-3), retinol, and calcium. Percent breast density was measured using Cumulus software. In age-adjusted analyses there was a positive association between 25(OH)D and percent breast density (P = 0.05; mean percent density = 11.3% vs. 15.6% for 1st vs. 4th quartile of 25(OH)D). Breast density was inversely associated with PTH (P = 0.05; 16.0% vs. 11.4% for Q1 vs. Q4) and positively associated with the IGF-1:IGFBP-3 molar ratio (P = 0.02; 11.9% vs. 15.6% for Q1 vs. Q4). However, these associations were all null after further adjustment for body mass index (BMI; P > 0.25). The independent relation between 25(OH)D and breast density remained null among subgroups defined by BMI and serum levels of retinol, calcium, and estradiol. These results suggest no strong independent associations between the circulating molecules of the vitamin D pathway and mammographic breast density in postmenopausal women. While it remains possible that vitamin D could influence breast cancer risk, our results suggest that such an effect would be mediated through pathways other than breast density.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21847642      PMCID: PMC3250989          DOI: 10.1007/s10549-011-1726-5

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  49 in total

1.  The quantitative analysis of mammographic densities.

Authors:  J W Byng; N F Boyd; E Fishell; R A Jong; M J Yaffe
Journal:  Phys Med Biol       Date:  1994-10       Impact factor: 3.609

2.  Quantitation of 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D by radioimmunoassay using radioiodinated tracers.

Authors:  B W Hollis
Journal:  Methods Enzymol       Date:  1997       Impact factor: 1.600

3.  Increased risk of malignant diseases after surgery for primary hyperparathyroidism. A nationwide cohort study.

Authors:  M Palmér; H O Adami; U B Krusemo; S Ljunghall
Journal:  Am J Epidemiol       Date:  1988-05       Impact factor: 4.897

4.  Quantification of serum 25-hydroxyvitamin D(2) and D(3) using HPLC-tandem mass spectrometry and examination of reference intervals for diagnosis of vitamin D deficiency.

Authors:  Amy K Saenger; Thomas J Laha; Deborah E Bremner; Sayed M H Sadrzadeh
Journal:  Am J Clin Pathol       Date:  2006-06       Impact factor: 2.493

5.  Vitamin D, calcium, and mammographic breast densities.

Authors:  Sylvie Bérubé; Caroline Diorio; Wendy Verhoek-Oftedahl; Jacques Brisson
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2004-09       Impact factor: 4.254

6.  Hyperparathyroidism and subsequent incidence of breast cancer.

Authors:  Karin B Michels; Fei Xue; Lena Brandt; Anders Ekbom
Journal:  Int J Cancer       Date:  2004-06-20       Impact factor: 7.396

7.  Serum levels of vitamin D metabolites and the subsequent risk of colon and rectal cancer in Finnish men.

Authors:  J Tangrea; K Helzlsouer; P Pietinen; P Taylor; B Hollis; J Virtamo; D Albanes
Journal:  Cancer Causes Control       Date:  1997-07       Impact factor: 2.506

8.  Circannual versus seasonal variations of longitudinally sampled 25-hydroxycholecalciferol serum levels.

Authors:  P Cugini; G Coen; D Scavo; P Lucia; S Mazzaferro; G Bianchini; C Massimetti; G Donato
Journal:  Biochem Med       Date:  1984-08

9.  PTHrP and the PTH/PTHrP receptor are co-expressed in human breast and colon tumours.

Authors:  J A Carron; W D Fraser; J A Gallagher
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

10.  Parathyroid hormone (PTH)/PTH-related protein (PTHrP) receptor expression and mitogenic responses in human breast cancer cell lines.

Authors:  M A Birch; J A Carron; M Scott; W D Fraser; J A Gallagher
Journal:  Br J Cancer       Date:  1995-07       Impact factor: 7.640

View more
  11 in total

1.  Urinary Magnesium and Other Elements in Relation to Mammographic Breast Density, a Measure of Breast Cancer Risk.

Authors:  Maria C Mora-Pinzon; Amy Trentham-Dietz; Ronald E Gangnon; Scott V Adams; John M Hampton; Elizabeth Burnside; Martin M Shafer; Polly A Newcomb
Journal:  Nutr Cancer       Date:  2018-03-14       Impact factor: 2.900

2.  Premenopausal plasma 25-hydroxyvitamin D, mammographic density, and risk of breast cancer.

Authors:  Kimberly A Bertrand; Bernard Rosner; A Heather Eliassen; Susan E Hankinson; Kathryn M Rexrode; Walter Willett; Rulla M Tamimi
Journal:  Breast Cancer Res Treat       Date:  2014-12-28       Impact factor: 4.872

3.  Vitamin D and calcium supplementation and one-year change in mammographic density in the women's health initiative calcium and vitamin D trial.

Authors:  Elizabeth R Bertone-Johnson; Anne McTiernan; Cynthia A Thomson; Jean Wactawski-Wende; Aaron K Aragaki; Thomas E Rohan; Mara Z Vitolins; Rulla M Tamimi; Karen C Johnson; Dorothy Lane; Kathryn M Rexrode; Jennifer D Peck; Rowan T Chlebowski; Gloria Sarto; Joann E Manson
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2012-01-17       Impact factor: 4.254

4.  Serum factors and clinical characteristics associated with serum E-screen activity.

Authors:  Jue Wang; Amy Trentham-Dietz; Jocelyn D C Hemming; Curtis J Hedman; Brian L Sprague
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2013-04-15       Impact factor: 4.254

5.  Increased vitamin D and calcium intake associated with reduced mammographic breast density among premenopausal women.

Authors:  Alecia Malin Fair; Toni J Lewis; Maureen Sanderson; William D Dupont; Sarah Fletcher; Kathleen M Egan; Anthony C Disher
Journal:  Nutr Res       Date:  2015-07-31       Impact factor: 3.315

6.  Associations of Sun Exposure with 25-Hydroxyvitamin D and Parathyroid Hormone Levels in a Cohort of Hypertensive Patients: The Graz Endocrine Causes of Hypertension (GECOH) Study.

Authors:  Stefan Pilz; Katharina Kienreich; Daniel Stückler; Andreas Meinitzer; Andreas Tomaschitz
Journal:  Int J Endocrinol       Date:  2012-02-16       Impact factor: 3.257

7.  Circulating insulin-like growth factor-I, insulin-like growth factor binding protein-3 and terminal duct lobular unit involution of the breast: a cross-sectional study of women with benign breast disease.

Authors:  Hisani N Horne; Mark E Sherman; Ruth M Pfeiffer; Jonine D Figueroa; Zeina G Khodr; Roni T Falk; Michael Pollak; Deesha A Patel; Maya M Palakal; Laura Linville; Daphne Papathomas; Berta Geller; Pamela M Vacek; Donald L Weaver; Rachael Chicoine; John Shepherd; Amir Pasha Mahmoudzadeh; Jeff Wang; Bo Fan; Serghei Malkov; Sally Herschorn; Stephen M Hewitt; Louise A Brinton; Gretchen L Gierach
Journal:  Breast Cancer Res       Date:  2016-02-18       Impact factor: 6.466

8.  Vitamin d: are we ready to supplement for breast cancer prevention and treatment?

Authors:  Katherine D Crew
Journal:  ISRN Oncol       Date:  2013-02-26

Review 9.  Why the stroma matters in breast cancer: insights into breast cancer patient outcomes through the examination of stromal biomarkers.

Authors:  Matthew W Conklin; Patricia J Keely
Journal:  Cell Adh Migr       Date:  2012-05-01       Impact factor: 3.405

10.  Circulating serum xenoestrogens and mammographic breast density.

Authors:  Brian L Sprague; Amy Trentham-Dietz; Curtis J Hedman; Jue Wang; Jocelyn Dc Hemming; John M Hampton; Diana Sm Buist; Erin J Aiello Bowles; Gale S Sisney; Elizabeth S Burnside
Journal:  Breast Cancer Res       Date:  2013-05-27       Impact factor: 6.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.